SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Rubicon Research Ltd Industry:  Pharmaceuticals - Indian - Formulations
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
544578 INE506V01022 76.3063838 RUBICON 0 12,701.43 80.14 9.62 1
Quarters :
ParticularsDec 2025(Rs.Cr)Sep 2025(Rs.Cr)Jun 2025(Rs.Cr)
Gross Sales301.71336.47278.03
Other Operating Income0.000.000.00
Other Income 4.301.511.44
Total Income306.01337.98279.46
Total Expenditure 239.46257.37214.89
PBIDT66.5580.6164.58
Interest 7.519.218.85
PBDT59.0471.4155.73
Depreciation9.519.788.30
Tax10.1219.1210.05
Fringe Benefit Tax0.000.000.00
Deferred Tax2.23-3.302.23
Reported Profit After Tax37.1845.8135.15
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item37.1845.8135.15
    
EPS (Unit Curr.)2.282.972.28
EPS (Adj) (Unit Curr.)2.282.972.28
Calculated EPS (Unit Curr.)2.262.972.28
Calculated EPS (Adj) (Unit Curr.)2.262.972.28
Calculated EPS (Ann.) (Unit Curr.)9.0311.879.12
Calculated EPS (Adj) (Ann.) (Unit Curr.)9.0311.879.12
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity16.4815.4415.41
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)22.0623.9623.23
PBDTM(%)19.5721.2220.04
PATM(%)12.3213.6112.64